PL2609925T3 - Siarczan dermatanu do zastosowania w leczeniu patologii, w których uczestniczą metaloproteinazy - Google Patents

Siarczan dermatanu do zastosowania w leczeniu patologii, w których uczestniczą metaloproteinazy

Info

Publication number: PL2609925T3
Authority: PL; Poland
Prior art keywords: metalloproteinases; pathologies; involved; treatment; dermatan sulfate
Prior art date: 2010-04-23

Application number

PL13161007T

Other languages

English (en)

Inventor

Giuseppe Claudio Viscomi

Ferdinando Mannello

Cristiana Bruno

Original Assignee

Alfasigma S.P.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-04-23

Filing date

2011-04-20

Publication date

2019-02-28

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43063923&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2609925(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2011-04-20 Application filed by Alfasigma S.P.A. filed Critical Alfasigma S.P.A.

2019-02-28 Publication of PL2609925T3 publication Critical patent/PL2609925T3/pl

Links

229920000045 Dermatan sulfate Polymers 0.000 title 1
102000005741 Metalloproteases Human genes 0.000 title 1
108010006035 Metalloproteases Proteins 0.000 title 1
AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 title 1
229940051593 dermatan sulfate Drugs 0.000 title 1
230000007170 pathology Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/727—Heparin; Heparan
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Molecular Biology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Cell Biology (AREA)
Hematology (AREA)
Developmental Biology & Embryology (AREA)
Communicable Diseases (AREA)
Diabetes (AREA)
Urology & Nephrology (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Oncology (AREA)
Immunology (AREA)
Virology (AREA)
Zoology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Dispersion Chemistry (AREA)
Enzymes And Modification Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL13161007T 2010-04-23 2011-04-20 Siarczan dermatanu do zastosowania w leczeniu patologii, w których uczestniczą metaloproteinazy PL2609925T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
ITBO2010A000250A IT1401253B1 (it)	2010-04-23	2010-04-23	Uso del sulodexide per la riduzione delle metalloproteinasi di matrice.
EP11723652.1A EP2560662B1 (en)	2010-04-23	2011-04-20	Sulodexide for use in the treatment of pathologies wherein metalloproteinases are involved
PCT/IB2011/051726 WO2011132161A2 (en)	2010-04-23	2011-04-20	Sulodexide for use in the treatment of pathologies wherein metalloproteinases are involved
EP13161007.3A EP2609925B1 (en)	2010-04-23	2011-04-20	Dermatan sulfate for use in the treatment of pathologies wherein metalloproteinases are involved

Publications (1)

Publication Number	Publication Date
PL2609925T3 true PL2609925T3 (pl)	2019-02-28

Family

ID=43063923

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
PL11723652T PL2560662T3 (pl)	2010-04-23	2011-04-20	Sulodeksyd do zastosowania w leczeniu patologii, w których uczestniczą metaloproteinazy
PL13161007T PL2609925T3 (pl)	2010-04-23	2011-04-20	Siarczan dermatanu do zastosowania w leczeniu patologii, w których uczestniczą metaloproteinazy

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
PL11723652T PL2560662T3 (pl)	2010-04-23	2011-04-20	Sulodeksyd do zastosowania w leczeniu patologii, w których uczestniczą metaloproteinazy

Country Status (11)

Country	Link
US (1)	US8987231B2 (pl)
EP (2)	EP2560662B1 (pl)
KR (2)	KR20160060164A (pl)
CN (1)	CN102883728A (pl)
ES (2)	ES2628582T3 (pl)
IT (1)	IT1401253B1 (pl)
MX (1)	MX339537B (pl)
PL (2)	PL2560662T3 (pl)
PT (2)	PT2609925T (pl)
RU (1)	RU2557996C2 (pl)
WO (1)	WO2011132161A2 (pl)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ITMI20061692A1 (it)	2006-09-05	2008-03-06	Alfa Wassermann Spa	Uso di polioli per ottenere forme polimorfe stabili di rifaximina
EP3060223B1 (en) *	2013-10-22	2017-08-30	Cell Receptor GmbH	Sulfated polysaccharides for use in the treatment of cancer
CN104398533B (zh) *	2014-11-26	2017-03-08	山东辰中生物制药有限公司	舒洛地特的生产方法
RU2667650C1 (ru) *	2017-12-15	2018-09-21	Федеральное государственное бюджетное образовательное учреждение высшего образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации	Способ лечения и профилактики острого тромбоза геморроидальных узлов

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2426586A1 (de)	1973-06-14	1975-01-09	Opocrin Srl	Verfahren zur herstellung von glukuronil-glukosamin-glykan-sulfaten mit antilipaemischer wirkung
US4705798A (en)	1985-09-27	1987-11-10	University Of Iowa Research Foundation	Phenylephrine prodrug useful as mydriatic agent
GB8827305D0 (en)	1988-11-23	1988-12-29	British Bio Technology	Compounds
IT1242604B (it) *	1990-11-13	1994-05-16	Alfa Wassermann Spa	Sali di glicosaminoglicani con esteri di aminoacidi, loro preparazione e formulazioni farmaceutiche che li contengono.
IT1245907B (it) *	1991-05-17	1994-10-25	Alfa Wassermann Spa	Uso dei glicosaminoglicani nel trattamento della nefropatia diabetica e della neuropatia diabetica.
GB9215665D0 (en)	1992-07-23	1992-09-09	British Bio Technology	Compounds
US5455258A (en)	1993-01-06	1995-10-03	Ciba-Geigy Corporation	Arylsulfonamido-substituted hydroxamic acids
HU219339B (en)	1993-09-30	2001-03-28	Seikagaku Kogyo Co Ltd	Dermatan sulphate with low heparin or heparane sulphate content and pharmaceutical compositions comprising them
IT1274351B (it)	1994-10-06	1997-07-17	Alfa Wassermann Spa	Uso di alcuni glicosaminoglicani nella dialisi peritoneale.
EA003294B1 (ru)	1995-12-08	2003-04-24	Агурон Фармасьютикалс, Инк.	Ингибиторы металлопротеиназы, фармацевтические композиции, их содержащие, и их фармацевтические применения
IT1285546B1 (it) *	1996-01-16	1998-06-18	Alfa Wassermann Spa	Uso del dermatano solfato a basso peso molecolare e delle specialita' medicinali che lo contengono nella terapia e nella prevenzione della
IT1299969B1 (it) *	1998-04-15	2000-04-04	Alfa Wassermann Spa	Uso di sulodexide e delle specialita' medicinali che lo contengono nel trattamento della retinopatia diabetica.
DE69833822D1 (de)	1998-10-01	2006-05-11	Giovanni Gambaro	Substanzen zur Vorbeugung von krankhafter TGF-beta Überexpression und Methoden derer Ermittlung
US20040009952A1 (en)	1998-10-19	2004-01-15	Giovanni Gambaro	TGF-beta gene overexpression preventing substances for the treatment of disorders connected with pathological overexpression of TGF-beta
IL127896A0 (en)	1998-12-31	1999-10-28	Gail Laster	A novel treatment for preeclampsia and related diseases
US20090325876A1 (en) *	2004-09-29	2009-12-31	Saul Yedgar	Use of lipid conjugates in the treatment of diseases associated with vasculature
US7259152B2 (en)	2000-06-07	2007-08-21	Alfa Wasserman, Inc.	Methods and compositions using sulodexide for the treatment of diabetic nephropathy
ATE290874T1 (de)	2000-12-16	2005-04-15	Aventis Pharma Gmbh	Verwendung von niedermolekularen heparin zur behandlung von osteoarthrose
FR2864087B1 (fr)	2003-12-19	2006-01-27	Aventis Pharma Sa	Derives carboxy-reduits du dermatan sulfate, leur preparation, leur application comme medicament et les compositions pharmaceutiques les renfermant
KR100808131B1 (ko) *	2006-06-22	2008-02-29	부경대학교 산학협력단	인간 섬유육종 세포에서 메트릭스 메탈로프로테이나제-9의발현을 억제시키는 카복실화 키토올리고사카라이드 화합물및 이를 함유한 메트릭스 메탈로프로테이나제-9 억제제
CN101632686A (zh) *	2008-04-04	2010-01-27	马斯特里赫特大学	糖胺聚糖用于修复糖萼的用途
GB0919054D0 (en)	2009-10-30	2009-12-16	Isis Innovation	Treatment of obesity

2010
- 2010-04-23 IT ITBO2010A000250A patent/IT1401253B1/it active
2011
- 2011-04-20 PT PT13161007T patent/PT2609925T/pt unknown
- 2011-04-20 WO PCT/IB2011/051726 patent/WO2011132161A2/en not_active Ceased
- 2011-04-20 EP EP11723652.1A patent/EP2560662B1/en not_active Revoked
- 2011-04-20 KR KR1020167013025A patent/KR20160060164A/ko not_active Ceased
- 2011-04-20 US US13/642,510 patent/US8987231B2/en active Active
- 2011-04-20 RU RU2012142256/15A patent/RU2557996C2/ru active
- 2011-04-20 MX MX2012012285A patent/MX339537B/es active IP Right Grant
- 2011-04-20 ES ES11723652.1T patent/ES2628582T3/es active Active
- 2011-04-20 PT PT117236521T patent/PT2560662T/pt unknown
- 2011-04-20 PL PL11723652T patent/PL2560662T3/pl unknown
- 2011-04-20 CN CN201180020126XA patent/CN102883728A/zh active Pending
- 2011-04-20 KR KR1020127027513A patent/KR101739757B1/ko active Active
- 2011-04-20 ES ES13161007.3T patent/ES2694587T3/es active Active
- 2011-04-20 EP EP13161007.3A patent/EP2609925B1/en not_active Not-in-force
- 2011-04-20 PL PL13161007T patent/PL2609925T3/pl unknown

Also Published As

Publication number	Publication date
WO2011132161A3 (en)	2012-03-08
RU2557996C2 (ru)	2015-07-27
PT2609925T (pt)	2018-11-22
RU2012142256A (ru)	2014-05-27
EP2609925A3 (en)	2013-09-04
PT2560662T (pt)	2017-07-10
WO2011132161A2 (en)	2011-10-27
MX2012012285A (es)	2012-11-23
US8987231B2 (en)	2015-03-24
MX339537B (es)	2016-05-30
PL2560662T3 (pl)	2017-09-29
KR20160060164A (ko)	2016-05-27
EP2560662B1 (en)	2017-06-07
KR101739757B1 (ko)	2017-05-25
ES2628582T3 (es)	2017-08-03
ES2694587T3 (es)	2018-12-21
EP2609925B1 (en)	2018-10-17
ITBO20100250A1 (it)	2011-10-24
EP2609925A2 (en)	2013-07-03
EP2560662A2 (en)	2013-02-27
IT1401253B1 (it)	2013-07-18
CN102883728A (zh)	2013-01-16
US20130045946A1 (en)	2013-02-21
KR20130072199A (ko)	2013-07-01

Publication	Publication Date	Title
GB201115711D0 (en)	2011-10-26	Phyto-cannabinoids for use in the treatment of cancer
ZA201207574B (en)	2014-09-25	Phytocannabinoids in the treatment of cancer
PL2652193T3 (pl)	2021-01-25	Obróbka
SG2014014724A (en)	2014-07-30	METHODS FOR THE TREATMENT OF IL-1ß RELATED CONDITIONS
PT2694107T (pt)	2018-11-27	Tratamento para patologias dermatológicas
AP3665A (en)	2016-04-13	Water treatment
IL225896A0 (en)	2013-06-27	Treatment of mecp-2 related disorders
ZA201209759B (en)	2014-03-26	Keloid treatment
IL224340A (en)	2015-10-29	Sanitary cause
ZA201305970B (en)	2014-04-30	Arylosulfonami for the treatment of cns diseases
ZA201307058B (en)	2015-08-26	Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment
PT2609925T (pt)	2018-11-22	Sulfato de dermatano para utilização no tratamento de patologias em que estão envolvidos metaloproteinases
GB201013573D0 (en)	2010-09-29	Treatment
GB201718726D0 (en)	2017-12-27	Phytocannabinoids in the treatment of cancer
PT2819655T (pt)	2016-10-14	Utilização de modafinil no tratamento de cocainómanos
TWM402081U (en)	2011-04-21	Bathtub
EP2531186A4 (en)	2013-07-17	TREATMENT OF HAIR DRESSES
PT2456445E (pt)	2014-07-17	Agente para o tratamento de condições da pele
GB201014097D0 (en)	2010-10-06	Treatment
HK1181301A (en)	2013-11-08	Sulodexide for use in the treatment of pathologies wherein metalloproteinases are involved
TWM386038U (en)	2010-08-11	Bath towel which can be worn
HUP1000688A2 (en)	2012-08-28	Use of trifluoro-phthalimides in the treatment of cancer
AU333202S (en)	2010-10-13	Tubs
PH32012000666S1 (en)	2012-10-08	Oval basin
GB201014963D0 (en)	2010-10-20	Therapeutic agents